These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34306493)
21. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae. Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052 [TBL] [Abstract][Full Text] [Related]
22. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E J Infect; 2015 Jun; 70(6):592-9. PubMed ID: 25447713 [TBL] [Abstract][Full Text] [Related]
23. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Zheng B; Dai Y; Liu Y; Shi W; Dai E; Han Y; Zheng D; Yu Y; Li M Front Microbiol; 2017; 8():1061. PubMed ID: 28659886 [No Abstract] [Full Text] [Related]
25. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013. Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F; J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590 [TBL] [Abstract][Full Text] [Related]
26. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. Falagas ME; Rafailidis PI; Kofteridis D; Virtzili S; Chelvatzoglou FC; Papaioannou V; Maraki S; Samonis G; Michalopoulos A J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829 [TBL] [Abstract][Full Text] [Related]
27. Risk Factors and Prognosis of Carbapenem-Resistant Zhang H; Wang J; Zhou W; Yang M; Wang R; Yan X; Cai Y Infect Drug Resist; 2021; 14():3297-3305. PubMed ID: 34447257 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757 [TBL] [Abstract][Full Text] [Related]
29. Risk factors and clinical outcomes of carbapenem-resistant Panda S; Dash A; Chhotray P; Nayak B; Mouli TC; Mishra SB Int J Crit Illn Inj Sci; 2022; 12(4):217-221. PubMed ID: 36779211 [TBL] [Abstract][Full Text] [Related]
30. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation. Vergadi E; Bitsori M; Maraki S; Galanakis E J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427 [TBL] [Abstract][Full Text] [Related]
31. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation. Brizendine KD; Richter SS; Cober ED; van Duin D Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105 [TBL] [Abstract][Full Text] [Related]
32. Carbapenem-Resistant Park SO; Liu J; Furuya EY; Larson EL Open Forum Infect Dis; 2016 Oct; 3(4):ofw222. PubMed ID: 27942542 [TBL] [Abstract][Full Text] [Related]
33. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents. Mills JP; Talati NJ; Alby K; Han JH Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382 [TBL] [Abstract][Full Text] [Related]
34. Risk Factors and Mortality of Elderly Patients with Hospital-Acquired Pneumonia of Carbapenem-Resistant Zhou C; Sun L; Li H; Huang L; Liu X Infect Drug Resist; 2023; 16():6767-6779. PubMed ID: 37881505 [TBL] [Abstract][Full Text] [Related]
35. Risk model and validation of carbapenem-resistant Liao Q; Feng Z; Chen X Open Med (Wars); 2023; 18(1):20230774. PubMed ID: 37663230 [TBL] [Abstract][Full Text] [Related]
36. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874 [TBL] [Abstract][Full Text] [Related]
38. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing. Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis. Li J; Li Y; Song N; Chen Y J Glob Antimicrob Resist; 2020 Jun; 21():306-313. PubMed ID: 31525540 [TBL] [Abstract][Full Text] [Related]
40. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study. Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]